NeuroCare Center, Inc.

Canton, Ohio 44718

0 studies enrolling now · 6 studies all time

What they study most

Alzheimer's Disease, Multiple Sclerosis, Parkinson's Disease, Relapsing Remitting Multiple Sclerosis, Stroke, Traumatic Brain Injury

Studies at this site

• Safety and Efficacy of AVP-923 for Pseudobulbar Affect in Multiple Sclerosis Patients — Completed
• Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter) — Completed
• Combination Therapy in Patients With Relapsing-Remitting Multiple Sclerosis (MS)CombiRx — Completed
• Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier) — Completed
• Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier) — Completed
• Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis — Completed